Fedora Daye, MPH
Senior Director, Global Regulatory Affairs
Fedora has more than 25 years of regulatory experience implementing regulatory strategies to minimize the time and capitol required to reach designated project milestones in nonclinical, clinical, and GMP manufacturing to commercialization. Fedora has managed the development of vaccines, small molecules, and medical devices (drug-device combinations), and acted as the liaison to the US FDA, European regulatory agency (EMA), Australian TGA, and other international regulatory bodies. As a contracted consultant; Fedora supported industry and academic clients in managing drug development programs and Tech Watch Programs for the US Army Department of Defense, Medical, Chemical and Biological Defense programs. Fedora received her Masters of Public Health from the University of North Carolina, at Chapel Hill.